Solulin increases clot stability in whole blood from humans and dogs with hemophilia. - Wikidata - awgldk - TriplyDB

Solulin increases clot stability in whole blood from humans and dogs with hemophilia.

Solulin increases clot stability in whole blood from humans and dogs with hemophilia.

http://www.wikidata.org/entity/Q35885322

about

Pharmacological targeting of the thrombomodulin-activated protein C pathway mitigates radiation toxicity Biomechanics of haemostasis and thrombosis in health and disease: from the macro- to molecular scale Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding.Thrombomodulin and the vascular endothelium: insights into functional, regulatory, and therapeutic aspects.Use of global assays to understand clinical phenotype in congenital factor VII deficiency.Recombinant thrombomodulin of different domains for pharmaceutical, biomedical, and cell transplantation applications.Effect of BAX499 aptamer on tissue factor pathway inhibitor function and thrombin generation in models of hemophilia.Clot lysis phenotype and response to recombinant factor VIIa in plasma of haemophilia A inhibitor patients.Tranexamic acid as adjunct therapy to bypassing agents in haemophilia A patients with inhibitors.FXIII: mechanisms of action in the treatment of hemophilia A.F376A/M388A-solulin, a new promising antifibrinolytic for severe haemophilia A.Thrombomodulin-dependent protein C activation is required for mitochondrial function and myelination in the central nervous system.Endogenous fibrinolytic potential in tissue-plasminogen activator-modified thromboelastography analysis is significantly decreased in dogs suffering from diseases predisposing to thrombosis.

P2860

Q24617126-00B149FD-B12F-4A6A-850C-22121BF54194 Q37294541-68281631-122E-4DC8-BFC5-C0A237C6EF9D Q37655890-C5F97CD3-03D7-4786-9792-2DABC79265E3 Q38100652-DF84688D-86F4-435C-9B11-D83D98C0DD60 Q38107520-1B3261A2-FFAA-4F9A-86A4-EC55DB1284F3 Q38117276-3D0CA0CA-4056-4A4A-B657-F3F403CCE2D7 Q42360054-19F53A08-FDA5-4A26-BB6F-78414D211D6B Q44514782-278971BA-9AE9-4EEE-987F-B01E8ACE42FA Q45851000-3F7A2D39-F2A9-4C05-BFEA-ACB707FA088B Q45859215-0BEE93D3-AA34-4B2A-9133-E3D5EA2A3FF7 Q45862673-EC1611D3-4654-4419-B507-4C400658576E Q46475919-E280AB93-1EC6-4475-B40A-773B0B59B05B Q47781348-7FF64E56-E0D7-44F5-9ED5-7AC3C7F7DB09

P2860

Solulin increases clot stability in whole blood from humans and dogs with hemophilia.

http://www.wikidata.org/entity/Q35885322

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Solulin increases clot stability in whole blood from humans and dogs with hemophilia.

@ast

Solulin increases clot stability in whole blood from humans and dogs with hemophilia.

@en

type

label

Solulin increases clot stability in whole blood from humans and dogs with hemophilia.

@ast

Solulin increases clot stability in whole blood from humans and dogs with hemophilia.

@en

prefLabel

Solulin increases clot stability in whole blood from humans and dogs with hemophilia.

@ast

Solulin increases clot stability in whole blood from humans and dogs with hemophilia.

@en

P1433

Q35885322-C56456A1-CEBF-41A4-9087-26D92196CED4

P1476

Q35885322-34DDE670-F28F-4DAF-BA93-F5B576C6C984

P2093

Q35885322-0DBE5EC6-874E-48A7-ADBC-08758A8923CF

Q35885322-53CC90C9-3533-44C3-B10B-C1489D8F07C2

Q35885322-5B1C6AE4-D357-438B-834D-C4DCF016F3E1

Q35885322-72B63527-2B02-4361-9DC5-04555A10C588

Q35885322-7E62ED88-E6EC-4345-B9F0-31CAE6951A88

Q35885322-A4DED24B-8A8A-46A6-95C4-40B33265D444

Q35885322-D8C2A9FE-18E2-4158-9FA2-2872E8F396B5

Q35885322-E3175B49-6B03-4429-B650-5EA757380120

P2860

Q35885322-05B7B7E2-95E5-4BE2-8086-1DC632B9F897

Q35885322-07D4C2C3-39A1-4A53-AFF8-D6CDD5488D0F

Q35885322-1096142D-F537-461C-AD3E-20FC68F82136

Q35885322-3E8B9812-408C-40D3-9F8E-658B0252D9DC

Q35885322-4815FC54-EC38-4483-BAEE-567B5A9C3563

Q35885322-5257A237-64B9-4C59-9FFC-5F0329C685F2

Q35885322-539E946D-7DA7-401E-9A83-951C7E664BB7

Q35885322-5FE3921D-FDE9-4905-B9C3-6093424539C8

Q35885322-62548BCE-320C-4FB4-9DF8-CBE39BEED92D

Q35885322-62920172-16D6-41FC-ACFA-42349F63D8E9

P304

Q35885322-27828B3C-1470-42DD-BB99-48F3E4007711

P31

Q35885322-A43A2656-F302-45D1-8B5D-A37D73FBC9EB

P356

Q35885322-913A29AA-530F-4448-A8F5-61B1104A1B09

P407

Q35885322-DDA481ED-C685-47FA-8CBB-C1B292F09F9A

P433

Q35885322-E82CA104-B671-43A5-A7FA-5A6B8149D6B6

P478

Q35885322-78D4D395-E813-492F-B417-CE8AD90ABC8D

P577

Q35885322-794B6EEB-B81E-43F5-A8A6-394D56129B30

P5875

Q35885322-092BD3E9-968A-47A3-9957-81BD5038F091

P698

Q35885322-C3CF2F08-EE83-4EB0-9755-26AC8FAFF89C

P921

Q35885322-D93C5095-082E-40FC-A1C3-EE2F24A23967

P932

Q35885322-B6925A3C-F789-4085-8FF0-65A1E3C85268

P356

BLOOD-2011-11-392308

P1433

P1476

Solulin increases clot stability in whole blood from humans and dogs with hemophilia.

@en

P2093

Benny Sørensen

http://www.w3.org/2001/XMLSchema#string

Catherine J Rea

http://www.w3.org/2001/XMLSchema#string

David Lillicrap

http://www.w3.org/2001/XMLSchema#string

Jonathan H Foley

http://www.w3.org/2001/XMLSchema#string

Karl-Uwe Petersen

http://www.w3.org/2001/XMLSchema#string

Lori Harpell

http://www.w3.org/2001/XMLSchema#string

Michael E Nesheim

http://www.w3.org/2001/XMLSchema#string

Sandra Powell

http://www.w3.org/2001/XMLSchema#string

P2860

The interaction of thrombomodulin with Ca2+

TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex

Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma

Aberrant splicing and premature termination of transcription of the FVIII gene as a cause of severe canine hemophilia A: similarities with the intron 22 inversion mutation in human hemophilia.

The molecular weights, mass distribution, chain composition, and structure of soluble fibrin degradation products released from a fibrin clot perfused with plasmin.

The hemophilias--from royal genes to gene therapy.

Kinetics of activated thrombin-activatable fibrinolysis inhibitor (TAFIa)-catalyzed cleavage of C-terminal lysine residues of fibrin degradation products and removal of plasminogen-binding sites

Prophylactic factor replacement in hemophilia.

Discordant fibrin formation in hemophilia.

Expanding hemophilia care in developing countries.

P304

3622-3628

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2011-11-392308

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221738031

http://www.w3.org/2001/XMLSchema#string

P698

22234684

http://www.w3.org/2001/XMLSchema#string

P921

P932

3325046

http://www.w3.org/2001/XMLSchema#string